M&A

Laprophan's acquisition of Rivopharm is more than a deal; it's a strategic blueprint for emerging market players aiming for the global pharmaceutical stage.

A merger of equals creates D.C.'s 7th largest bank. ODNB and NACB unite, promising big returns for investors and a new era for community banking.

With key hires from the semiconductor world and AWS, SambaNova isn't just growing. It's making a high-stakes bet on premium inference and autonomous AI.

The chip titan's debt buyback isn't just financial housekeeping. It's a strategic deleveraging to reload for future acquisitions in the AI arms race.

Stunning head-to-head trial data shows Takeda's zasocitinib is 2.5x more effective than its rival, signaling a major market disruption and validating a landmark deal.

EQT appoints M&A mastermind Gustav Segerberg as CFO, signaling a doubling-down on its aggressive growth strategy. What does this mean for its future?

As TopBuild shareholders face a critical merger deadline, QXO is assembling an industry titan. This move isn't just about size; it's a bid to reshape the future.

After three rejected offers, Diana Shipping escalates its hostile bid for Genco, now urging shareholders to replace the entire board in a proxy fight.

With top marks from AM Best, Ryan Specialty expands in Asia while streamlining in Europe, showcasing a masterclass in specialty insurance leadership.

QXO plans a $3B notes offering to fund its massive TopBuild acquisition. This debt-fueled move aims for market leadership but raises leverage concerns.

Columbia Distributing's major investment in Hayden Beverage reshapes the regional market, promising vast reach but raising questions for local brands.

A new guide by a veteran attorney argues personal injury law is at a breaking point. Firms must embrace AI or risk being consumed by new market forces.

MAI Capital acquires Dallas-based Service Academy Capital Management, expanding its UHNW division and targeting Texas's booming ultra-wealthy market.

Facing a severe cash crunch, Jasper Therapeutics is exploring a sale or even a shutdown, placing the future of its promising urticaria drug, briquilimab, in limbo.

Tradewinds Universal is moving to Las Vegas to build a public nightlife conglomerate. Can transparency legitimize an industry long kept in the shadows?

Bragg Gaming Group announces a $1.3M private placement, backed by insiders and industry titan Matt Davey, to fuel its transformative Drayton acquisition.

Winston & Strawn and Taylor Wessing complete their historic merger, creating a $1.75B firm poised to reshape the global legal landscape for key sectors.

Texas-based Ryan joins forces with Svalner Atlas in a reported $400M deal, creating a major challenger to the Big Four in Europe's tax advisory market.

Canadian software giant Topicus.com's A$2.00 per share offer for ReadyTech was swiftly rejected, setting the stage for a high-stakes corporate showdown.

AMTD Group expands its Malaysian footprint with a pricey hotel deal, linking it to film and media. But questions linger about its strategy and valuation.